EUTOS for CML is a unique collaboration between the European LeukemiaNet and Novartis Oncology in Europe
There are currently no items in Calendar!
The EUropean Treatment Outcome Study (EUTOS) is a collaboration between the European LeukemiaNet ELN and Novartis started in June 2007 running initially for 3 years to improve understanding of CML, promote best practise, and enhance treatment outcomes, through 4 key projects:
The initial collaboration has now been extended for two additional years (2011-2012), encompassing the following workstreams:
Major aims of the cooperation are to:
Created by: A. Hellenbrecht , generated 2007/12/19 , last changed: 2011/07/21